Nazartinib (EGF816) in patients with treatment-na ve EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results.
Nazartinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Nazartinib (EGF816) in patients with treatment-na ve EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results. ### Output: Nazartinib